Also in vitro, overexpression of a constitutively active variant of NFκB can rescue stem cell signal-depleted AML cells from apoptosis; this rescue can be attributed to the expression of NFκB downstream target genes such as apoptosis regulator BCL2 [65,66]. Here, BCL2 is linked to acute myeloid leukemia.